ARCHIVES

Single-Agent Phase III Trial Comparing Vectibix to Erbitux Meets Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 36 No. 5 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

Strict Regulation Of Tobacco Products Proposed in Senate

November 24, 1989

Dingell Subcommittee Report Next Month To Include New Info

July 1, 1994

Dana-Farber Correction Plan Sent To State; Pharmacy Chief Resigns

June 9, 1995

NCI Forms Lung Cancer Program for Research On Early Detection, Treatment.

June 23, 2006

In Brief: DeVita, FDA Chief Help Kill California Bill Legalizing Laetrile Wit committee Testimony

August 26, 1977

Working Group To Review NCI Clinical Trials Programs

April 12, 1996